Evaluation of Laboratory Abnormalities in an Addict Population: A Patient Profile

  • Bruce D. Miller
  • Ahmed Nakah


Most of the studies on the medical and laboratory abnormalities found in heroin addicts have focused on specific, predictably abnormal parameters and attempted to quantitate the degree and significance of such laboratory abnormalities. The majority of such investigations have involved relatively small numbers of patients who are most often taken from selected populations, i.e., hospital clinics, in-patient settings, city morgues, etc.1–8 The usefulness of these studies in predicting or describing general trends in heroin addicts is somewhat limited by their selectivity.


Laboratory Abnormality Drug Addict Heroin Addict Serum Glutamic Pyruvic Transaminase Drug Treatment Program 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.


Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.


  1. Treser, G., Cherubin, C., et al. 1974. Renal Lesions in Narcotic Addicts. Amer. J. Med., 57: 687.CrossRefGoogle Scholar
  2. Cushman, P., Jr., Grieco, M.H. 1973. Hyper immunoglobulinemia Associated with Narcotic Addiction. Amer. J. Med., 54: 320.CrossRefGoogle Scholar
  3. Gorodetzky, C.W., Sapira, J.D., et al. 1968. Liver Disease in Narcotic Addicts. Clin. Pharmacol. and Therapeut., 9(6): 720.Google Scholar
  4. Cherubin, C.E., et al. 1972. Chronic Liver Disease in Asymptomatic Narcotic Addicts. Ann. Intern. Med., 76: (3) 391.Google Scholar
  5. Cherubin, C.E., et al. 1972. Persistence of Transaminase Abnormalities in Former Drug Addicts. Ann. Intern. Med., 76(3): 385.Google Scholar
  6. Cherubin, C.E., Hargrove, R.L. and Prince, A.M. 1970. The Serum Hepatitis Related Antigen (SH) in Illicit Drug Users. Amer. J. Epidemiol., 91(5): 510.Google Scholar
  7. Hunter, J., et al. 1971. The Australia (Hepatitis Associated) Antigen Amongst Heroin Addicts Attend-ng a London Addiction Clinic. J. Hyg., Camb. 61: 565.CrossRefGoogle Scholar
  8. Marks, V. and Chapple, P.A.L. 1966. Heptic Dysfunction in Heroin and Cocaine Users. Brit. J. Addict., 62: 189.CrossRefGoogle Scholar
  9. Schoenfeld, M.R. and Samala, R. 1966. Absence of Anemia in Hep- atitis Due to Heroin Addiction: Evidence for Tendency to Erythrocytosis Among Heroin Addicts. J. New Drugs, 6: 149.Google Scholar
  10. Degroote, J., et al. 1968. A Classification of Chronic Hepatitis. Lancet, 626–629.Google Scholar
  11. Sapira, J.D., Jasinski, D.R. and Gorodetzky, C.W. 1968. Liver Disease in Narcotic Addicts. II. The Role of the Needle. Clin. Pharmacol. and Therapeut., 9(6): 725.Google Scholar
  12. Lum, G. and Gambino, S.R. 1972. Serum Gamma Glutamyl Transpeptidase Activity as an Indicator of Disease of Liver, Pancreas or Bone. Clin. Chem., 18(4): 358.Google Scholar
  13. Louria, D.B., Hensle, T. and Rose, J. 1967. The Major MedicalGoogle Scholar
  14. Complications of Heroin Addiction. Ann. Intern. Med., 67(1).Google Scholar
  15. Cherubin, C.E., Millan, S.J. 1968. Serological Investigations in Narcotic Addicts. Ann. Intern. Med., 64: 15.Google Scholar

Copyright information

© Plenum Press, New York 1981

Authors and Affiliations

  • Bruce D. Miller
    • 1
  • Ahmed Nakah
    • 1
  1. 1.DenverUSA

Personalised recommendations